
Ionis Pharma (IONS) Earnings Dates & Reports
Ionis Pharma (IONS) Most Recent Earnings
Report Date
Period EndingQ3 2025
Est. EPS-$1.12
Actual EPS-$0.61
EarningsBeat
Ionis Pharma (IONS) Earnings
View the latest Ionis Pharma (IONS) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in Ionis Pharma (IONS)
Order type
Buy in
Order amount
Est. shares
0 shares
Ionis Pharma (IONS) Earnings per Share (EPS) History
Signup for full accessBrowse free
Ionis Pharma (IONS) Latest Earnings
The value each IONS share was expected to gain vs. the value each share gained.
Ionis Pharma (IONS) reported its most recent earnings on for Q3 2025, posting earnings per share (EPS) of -$0.61. This exceeded analysts' expectations of -$1.12 by 45.27%, marking a Beat.
For comparison, Ionis Pharma reported EPS of -$0.72 in the same quarter last year.
The company is expected to announce its next earnings report on , with analysts projecting an EPS of -$1.25.
Ionis Pharma (IONS) Earnings History
Ionis Pharma (IONS) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the Ionis Pharma’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
| Report date | Price 1D before | Price 1D after | Change |
|---|---|---|---|
| — | — | — | |
| — | — | — | |
| — | — | — | |
| — | — | — |
Ionis Pharma (IONS) Earnings FAQs
Ionis Pharma (IONS) last reported earnings on Oct 29, 2025 for Q3 2025, posting an EPS of -$0.61, which Beat the estimate of -$1.12 by 45.27%.
For Q3 2025, Ionis Pharma (IONS) reported an EPS of -$0.61, exceeding analysts' estimate of -$1.12 by 45.27%.
For Q3 2025, Ionis Pharma (IONS) Beat expectations with an actual EPS of -$0.61 vs. an estimated EPS of -$1.12.
Following the last earnings report on Oct 29, 2025, Ionis Pharma (IONS)'s stock price moved — from — to —.
The next Ionis Pharma (IONS) earnings call is scheduled for Feb. 18, 2026, where executives will discuss financial results and outlook.